Olvanil

CAS No. 58493-49-5

Olvanil ( N-Vanillyloleamide; N-Vannilyloleoylamide )

Catalog No. M27675 CAS No. 58493-49-5

Olvanil is a vanilloid receptor agonist with EC50 of 0.7nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 102 Get Quote
5MG 170 Get Quote
10MG 250 Get Quote
25MG 428 Get Quote
50MG 614 Get Quote
100MG 853 Get Quote
500MG 1692 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Olvanil
  • Note
    Research use only, not for human use.
  • Brief Description
    Olvanil is a vanilloid receptor agonist with EC50 of 0.7nM.
  • Description
    Olvanil is a vanilloid receptor agonist with EC50 of 0.7nM.(In Vitro):Olvanil affects C6 glioma cell proliferation with IC50 of 5.5 μM.(In Vivo):Olvanil is one capsaicin analog. Olvanil acts as an agonist at the vanilloid receptor. Olvanil may have causes an anxiogenic-like effect. Doses of 0, 0.2, 1.0 and 5.0 mg/kg Olvanil, respectively, yielded percent open arm entries at 5 min of 25±10.1, 19.3±7.1, 14.9±5.9 and 0±0.
  • Synonyms
    N-Vanillyloleamide; N-Vannilyloleoylamide
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    TRP/TRPV Channel
  • Recptor
    HDAC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    58493-49-5
  • Formula Weight
    417.6
  • Molecular Formula
    C26H43NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCCCCC\C=C/CCCCCCCC(=O)NCc1ccc(O)c(OC)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Han-Li Huang, et al. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis. Theranostics. 2019 Sep 18;9(22):6676-6689.
molnova catalog
related products
  • Mavatrep

    A selective, high-affinity TRPV1 antagonist with IC50 of 4.6 nM (inhibition of capsaicin-induced Ca(2+) influx).

  • JNJ-38893777

    JNJ-38893777 is a potent and selective transient receptor potential vanilloid 1 (TRPV1) channel antagonist for treatment of ociceptive and neuropathic pain.

  • GSK2193874

    GSK2193874 was identified as a selective orally active TRPV4 blocker.